Xtrenbo (Xgeva, Biosimilars of Xgeva)

This medicine guide is specific to Xgeva and its Biosimilars.

Denosumab is used to stop bone problems in people with multiple myeloma or growths that have actually infected the bone.

Denosumab is likewise made use of in grownups and children a minimum of 12 years and older with a completely developed bone structure to treat giant cell tumor of bone that can not be removed with surgical procedure.

Denosumab is additionally utilized to treat high calcium degrees in the blood caused by cancer when a certain kind of medicine made use of to reduced blood calcium degrees has not worked.

Denosumab may additionally be utilized for objectives not detailed in this medication overview.

You need to not obtain denosumab if you have low levels of calcium in your blood (hypocalcemia). Your low blood calcium will certainly require to be dealt with prior to you receive denosumab.

You need to not obtain denosumab if you are allergic to it or if you have low levels of calcium in your blood (hypocalcemia). Your reduced blood calcium will certainly need to be treated prior to you receive denosumab.

You should not use any other medicines which contain denosumab while you are receiving Xtrenbo.

Inform your medical professional if you have or have actually ever before had:

• reduced levels of calcium in your blood (hypocalcemia);.
• osteoporosis or damaged bones;.
• if you are set up for a dental procedure;.
• if you can not take daily calcium and vitamin D;.
• if you are taking medication that decreases your blood calcium degrees; or.
• kidney disease (or if you are on dialysis).

Denosumab might cause very low degrees of calcium in your blood (hypocalcemia), which can bring about fatality. Talk with your physician about this danger.

This medicine may create jaw bone problems (osteonecrosis). The threat is highest possible in individuals with cancer cells, blood cell conditions, pre-existing dental troubles, or people treated with steroids, chemotherapy, or radiation. Ask your medical professional regarding your own danger.

May damage an unborn infant. Do not utilize if you are pregnant. You may need a maternity examination prior to beginning this treatment. Usage reliable birth control while getting denosumab and for a minimum of 5 months after your last dose. Inform your medical professional if you conceive.

Ask a medical professional if it is risk-free to breastfeed while using this medicine.

Obtain emergency clinical aid if you have indicators of an allergy: hives, challenging breathing, swelling of your face, lips, tongue, or throat.

Xtrenbo may create severe side effects. Call your doctor at the same time if you have:

• new or unusual discomfort in your thigh, hip, or groin;
• jaw discomfort or tingling, red or inflamed gum tissues, loosened teeth, or slow recovery after oral job; or
• reduced blood calcium-- muscle spasms or contractions, pins and needles or tingly feeling (around your mouth, or in your fingers and toes).

After you stop making use of denosumab, inform your doctor if you have signs of high calcium degrees (hypercalcemia) such as confusion, tiredness, queasiness, throwing up, loss of appetite, bowel irregularity, raised thirst or urination, weight reduction.

Typical negative effects of Xtrenbo might consist of:

• exhaustion, absence of power;
• rash, shortness of breath;
• abnormal blood tests;
• nausea, throwing up, looseness of the bowels, irregular bowel movements, anorexia nervosa;
• migraine, back or joint pain, pain or swelling in your arms or legs; or
• cool signs such as stuffy nose, sneezing, sore throat.

This is not a full listing of side effects and others might happen. Call your physician for clinical suggestions concerning side effects. You may report negative effects to FDA at 1-800-FDA-1088.

Denosumab is injected under the skin. A healthcare provider will give you this injection.

Denosumab is usually given once every 4 weeks. You may need to receive additional doses depending on the condition being treated. Follow your doctor's instructions.

Your blood will need to be tested often. Your doctor may have you take extra calcium and vitamin D while you are being treated with denosumab. Take only the amount of calcium and vitamin D that your doctor has prescribed.

If you need to have any dental work (especially surgery), tell the dentist ahead of time that you are receiving denosumab.

Pay special attention to your dental hygiene. Brush and floss your teeth regularly while receiving this medication. You may need to have an oral examination before you begin treatment with denosumab. Follow your doctor's instructions.

Your risk of bone fractures can increase when you stop using denosumab. Do not stop using this medicine without first talking to your doctor.

If you keep this medicine at home, store it in the original carton in a refrigerator. Protect from light and do not freeze. Do not shake the medicine.

After you have taken denosumab out of the refrigerator, you may keep it at room temperature for up to 14 to 63 days, depending on the brand form. Store in the original container away from heat and light.

Call your physician for directions if you miss out on a visit for your denosumab injection.

Look for emergency situation medical focus or call the Poison Help line at 1-800-222-1222.

Follow your physician's guidelines concerning any kind of constraints on food, drinks, or task.

Other medicines might influence denosumab, consisting of prescription and over-the-counter medications, vitamins, and natural products Tell your doctor about all various other medicines you make use of.

Biosimilar and interchangeable products are organic items that are highly comparable to and have no clinically purposeful distinctions from the recommendation item.

Reference products

These are biological items that have currently been accepted by the FDA, versus which biosimilar products are compared. There are 2 for Xtrenbo.

Prolia (denosumab) - Amgen Inc

.|Formulation kind |

Toughness|| Pre-Filled Syringe|60 mg/mL|| Single-Dose Vial|60 mg/mL Discontinued |

View Prolia details thoroughly.

Xgeva( denosumab)- Amgen Inc.|Formula type|Toughness|| Single-Dose Vial |

120 mg/1.7 mL( 70 mg/mL) |

View Xgeva info in detail.

Prolia, Xgeva compatible items. Interchangeable biosimilar products can be dispensed by a pharmacologist without the intervention of the prescriber of the recommendation item.

Drug store laws for biosimilar prescribing may differ by state.

Aukelso (denosumab-kyqq) - Biocon Biologics Inc

.|Formulation type |

Toughness|| Single-Dose Vial |

120 mg/1.7 mL( 70 mg/mL) |

View Aukelso details thoroughly. Bildyos( denosumab-nxxp)- Shanghai

Henlius Biotech, Inc.|Solution type|Toughness||

Pre-Filled Syringe|60 mg/mL |

60 mg/mL|View Bildyos information in detail. Bilprevda( denosumab-nxxp)- Shanghai Henlius Biotech, Inc

.|Formulation kind |

Stamina|| Single-Dose Vial |

120 mg/1.7 mL( 70 mg/mL) |

View Bilprevda info carefully. Bomyntra( denosumab-bnht )- Fresenius Kabi USA, LLC|Solution kind|Strength|| Pre-Filled Syringe|120 mg/1.7 mL (70 mg/mL)|| Single-Dose Vial|120 mg/1.7 mL( 70 mg/mL )|

Sight Bomyntra info in detail. Boncresa (denosumab-mobz )- Amneal Pharmaceuticals LLC|Formulation kind|Strength||

Pre-Filled Syringe |

60 mg/mL|View Boncresa details in detail.

Bosaya( denosumab-kyqq)- Biocon Biologics Inc.|Solution kind|Stamina||

Pre-Filled Syringe |

60 mg/mL|View Bosaya details in detail.

Conexxence (denosumab-bnht)- Fresenius Kabi USA, LLC|Formula kind|Toughness||

Pre-Filled Syringe |

60 mg/mL|View Conexxence info carefully.

Degevma( denosumab-adet )- Teva Pharmaceuticals, Inc.

Single-Dose Vial|120 mg/1.7 mL( 70 mg/mL) |

Degevma Enoby( denosumab-qbde)- Hikma Pharmaceuticals USA Inc.

60 mg/mL|View Jubbonti info in detail.

Jubereq( denosumab-desu )- Accord BioPharma Inc.

Single-Dose Vial |

120 mg/1.7 mL( 70 mg/mL) |

Sight Jubereq information carefully. Osenvelt (denosumab-bmwo)- CELLTRION, Inc.|Formula kind |

Toughness||

Single-Dose Vial|120 mg/1.7 mL( 70 mg/mL )| View Osenvelt information in detail. Ospomyv( denosumab-dssb)- Samsung Bioepis Co., Ltd. |

Formulation kind |

Stamina|| Pre-Filled Syringe|60 mg/mL|View Ospomyv details in detail. Osvyrti( denosumab-desu)- Accord BioPharma Inc. |

Solution type |

Strength|| Pre-Filled Syringe|60 mg/mL|Sight Osvyrti information carefully. Oziltus( denosumab-mobz)- Amneal Pharmaceuticals LLC|Formula kind |

Toughness||

Single-Dose Vial|120 mg/1.7 mL( 70 mg/mL)|View Oziltus details in detail. Ponlimsi (denosumab-adet)- Teva Pharmaceuticals, Inc.|Formulation kind |

Stamina|| Pre-Filled Syringe|60 mg/mL|Ponlimsi Stoboclo (denosumab-bmwo)- CELLTRION, Inc.

Sight Stoboclo info thoroughly.

Wyost( denosumab-bbdz)- Sandoz Inc.|Formula type|Toughness|| Single-Dose Vial |

120 mg/1.7 mL( 70 mg/mL) |

View Wyost information thoroughly. Xbryk( denosumab-dssb) - Samsung Bioepis Co., Ltd

.|Solution kind |

Toughness|| Single-Dose Vial |

120 mg/1

.7 mL (70 mg/mL)|Xbryk Xtrenbo( denosumab-qbde)- Hikma Pharmaceuticals USA Inc

.|Formula type|Toughness |